Document is current
Any future updates will be listed below
-
Authors
Tsuruta, James K.
Sears, Patrick R.
Rebuli, Meghan E.
Weitz, Andrew S.
Durham, Phillip G.
Clapp, Phillip W.
Hill, David B.
Ostrowski, Lawrence E.
Dayton, Paul A.
Caughey, Melissa C.
-
Funding
Funding for this research was provided by:
Cystic Fibrosis Foundation (CAUGHE23GO)
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 22 November 2024
First Online: 1 December 2024
Declarations
:
: Drs. Tsuruta, Weitz, Durham, Clapp, Hill, Dayton, and Caughey are co-inventors on a pending patent describing a microbubble ultrasound contrast agent optimized for muco-adhesion and pulmonary imaging. Dr. Dayton declares ownership interest in SonoVascular and Triangle Biotechnology, as well as intellectual property licenses and royalties from Revvity, Triangle Biotechnolgy, and SonoVascular. Drs. Sears, Rebuli, and Ostrowski report no competing interests.
